Delivery Order SPE2DB22D3009-SPE2DB25FBC99
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Fexofenadine HCL 180 mg tablets (500-count) valued at $1,022.88 under a firm fixed-price contract. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fexofenadine HCL 180 mg tablets (100-count packages) under a firm fixed-price contract valued at $1,149.62. The award was made on June 4, 2025, with an ultimate completion date of June 5, 2025, and represents a non-competitive, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Fexofenadine HCL 180 mg tablets in a quantity of 500 units, valued at $2,287.74. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of September 9, 2025. The award represents a child delivery order under a larger contract vehicle,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Fexofenadine HCl 180 mg tablets (500 count) with a ceiling value of $1,288.32. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Fexofenadine HCL 180 mg tablets (500 count) with a contract ceiling value of $1,811.12. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract was competitively awarded without a set-aside designation, and performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Fexofenadine HCl 180 mg tablets in quantities of 500 units, valued at $1,674.10. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set for ultimate completion by May 7, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. As a major pharmaceutical distributor and...
- This is a $1,931.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Fexofenadine HCL 180 mg tablets, a prescription medication, with a period of performance through July 2, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,760.02 firm fixed price contract provides 4,562,878,752 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,558,533 units of Fexofenadine HCL 180 mg tablets. The $1,340.43 ceiling value contract has a completion date of September 21, 2022. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov) until June 2025, has an extensive history of providing pharmaceutical and medical products...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,810,234 units of Fexofenadine HCL 180 mg tablets, with a total ceiling value of $21,068.52 and a period of performance through December 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBC99Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,265.19 to AmerisourceBergen Drug Corp for Fexofenadine HCL 180 mg tablets (500 count) with an ultimate completion date of August 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The delivery location is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating capability to meet federal procurement requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/12/25 |